nodes	percent_of_prediction	percent_of_DWPC	metapath
Propofol—CYP2C8—Spironolactone—dilated cardiomyopathy	0.179	0.531	CbGbCtD
Propofol—ALB—Furosemide—dilated cardiomyopathy	0.158	0.469	CbGbCtD
Propofol—Metabolic acidosis—Furosemide—dilated cardiomyopathy	0.0178	0.0388	CcSEcCtD
Propofol—Hyperkalaemia—Spironolactone—dilated cardiomyopathy	0.0127	0.0277	CcSEcCtD
Propofol—Hypomagnesaemia—Furosemide—dilated cardiomyopathy	0.0111	0.0241	CcSEcCtD
Propofol—Thrombosis—Furosemide—dilated cardiomyopathy	0.00996	0.0217	CcSEcCtD
Propofol—Injection site pain—Furosemide—dilated cardiomyopathy	0.00864	0.0188	CcSEcCtD
Propofol—Cramp muscle—Spironolactone—dilated cardiomyopathy	0.00847	0.0184	CcSEcCtD
Propofol—Hyperlipidaemia—Lisinopril—dilated cardiomyopathy	0.00734	0.016	CcSEcCtD
Propofol—Renal failure—Spironolactone—dilated cardiomyopathy	0.00713	0.0155	CcSEcCtD
Propofol—Ventricular fibrillation—Lisinopril—dilated cardiomyopathy	0.00691	0.015	CcSEcCtD
Propofol—Mental disability—Furosemide—dilated cardiomyopathy	0.00612	0.0133	CcSEcCtD
Propofol—Ventricular extrasystoles—Lisinopril—dilated cardiomyopathy	0.00586	0.0127	CcSEcCtD
Propofol—Oliguria—Lisinopril—dilated cardiomyopathy	0.00574	0.0125	CcSEcCtD
Propofol—Leukocytosis—Lisinopril—dilated cardiomyopathy	0.00563	0.0122	CcSEcCtD
Propofol—Creatinine increased—Lisinopril—dilated cardiomyopathy	0.00556	0.0121	CcSEcCtD
Propofol—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00545	0.0118	CcSEcCtD
Propofol—Ventricular tachycardia—Lisinopril—dilated cardiomyopathy	0.00529	0.0115	CcSEcCtD
Propofol—Anaphylactoid reaction—Furosemide—dilated cardiomyopathy	0.00529	0.0115	CcSEcCtD
Propofol—Hyperkalaemia—Lisinopril—dilated cardiomyopathy	0.0052	0.0113	CcSEcCtD
Propofol—Salivary hypersecretion—Lisinopril—dilated cardiomyopathy	0.00514	0.0112	CcSEcCtD
Propofol—Wheezing—Lisinopril—dilated cardiomyopathy	0.00514	0.0112	CcSEcCtD
Propofol—Blood urea increased—Lisinopril—dilated cardiomyopathy	0.00499	0.0109	CcSEcCtD
Propofol—Neuropathy—Lisinopril—dilated cardiomyopathy	0.00497	0.0108	CcSEcCtD
Propofol—Urinary retention—Furosemide—dilated cardiomyopathy	0.00487	0.0106	CcSEcCtD
Propofol—Blood creatinine increased—Furosemide—dilated cardiomyopathy	0.00479	0.0104	CcSEcCtD
Propofol—Dehydration—Furosemide—dilated cardiomyopathy	0.00476	0.0104	CcSEcCtD
Propofol—Pulmonary oedema—Lisinopril—dilated cardiomyopathy	0.00471	0.0102	CcSEcCtD
Propofol—Confusional state—Spironolactone—dilated cardiomyopathy	0.00466	0.0101	CcSEcCtD
Propofol—Hypertonia—Lisinopril—dilated cardiomyopathy	0.00464	0.0101	CcSEcCtD
Propofol—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00462	0.0101	CcSEcCtD
Propofol—Cramp muscle—Furosemide—dilated cardiomyopathy	0.00461	0.01	CcSEcCtD
Propofol—Pancreatitis—Furosemide—dilated cardiomyopathy	0.00434	0.00943	CcSEcCtD
Propofol—Somnolence—Spironolactone—dilated cardiomyopathy	0.00411	0.00894	CcSEcCtD
Propofol—Atrial fibrillation—Lisinopril—dilated cardiomyopathy	0.00405	0.00882	CcSEcCtD
Propofol—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.00399	0.00868	CcSEcCtD
Propofol—Anaphylactoid reaction—Lisinopril—dilated cardiomyopathy	0.00397	0.00863	CcSEcCtD
Propofol—Renal failure—Furosemide—dilated cardiomyopathy	0.00388	0.00843	CcSEcCtD
Propofol—Diplopia—Lisinopril—dilated cardiomyopathy	0.00384	0.00835	CcSEcCtD
Propofol—Pain in extremity—Lisinopril—dilated cardiomyopathy	0.00384	0.00835	CcSEcCtD
Propofol—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00381	0.00829	CcSEcCtD
Propofol—Urticaria—Spironolactone—dilated cardiomyopathy	0.00367	0.00799	CcSEcCtD
Propofol—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00366	0.00795	CcSEcCtD
Propofol—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.00365	0.00794	CcSEcCtD
Propofol—Blood creatinine increased—Lisinopril—dilated cardiomyopathy	0.0036	0.00783	CcSEcCtD
Propofol—Dehydration—Lisinopril—dilated cardiomyopathy	0.00357	0.00777	CcSEcCtD
Propofol—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.00346	0.00752	CcSEcCtD
Propofol—Visual impairment—Furosemide—dilated cardiomyopathy	0.00341	0.00742	CcSEcCtD
Propofol—Tinnitus—Furosemide—dilated cardiomyopathy	0.0033	0.00718	CcSEcCtD
Propofol—Pruritus—Spironolactone—dilated cardiomyopathy	0.00327	0.00712	CcSEcCtD
Propofol—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.00326	0.0071	CcSEcCtD
Propofol—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.00325	0.00708	CcSEcCtD
Propofol—Sweating increased—Lisinopril—dilated cardiomyopathy	0.00323	0.00703	CcSEcCtD
Propofol—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00316	0.00688	CcSEcCtD
Propofol—Arrhythmia—Furosemide—dilated cardiomyopathy	0.00316	0.00688	CcSEcCtD
Propofol—Erythema—Furosemide—dilated cardiomyopathy	0.00308	0.0067	CcSEcCtD
Propofol—Dizziness—Spironolactone—dilated cardiomyopathy	0.00306	0.00665	CcSEcCtD
Propofol—Dysgeusia—Furosemide—dilated cardiomyopathy	0.00302	0.00657	CcSEcCtD
Propofol—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.00299	0.00651	CcSEcCtD
Propofol—Muscle spasms—Furosemide—dilated cardiomyopathy	0.00296	0.00645	CcSEcCtD
Propofol—Depression—Lisinopril—dilated cardiomyopathy	0.00295	0.00642	CcSEcCtD
Propofol—Vomiting—Spironolactone—dilated cardiomyopathy	0.00294	0.0064	CcSEcCtD
Propofol—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.00292	0.00635	CcSEcCtD
Propofol—Rash—Spironolactone—dilated cardiomyopathy	0.00292	0.00634	CcSEcCtD
Propofol—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00291	0.00634	CcSEcCtD
Propofol—Renal failure—Lisinopril—dilated cardiomyopathy	0.00291	0.00633	CcSEcCtD
Propofol—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.0029	0.00631	CcSEcCtD
Propofol—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.0029	0.00631	CcSEcCtD
Propofol—Headache—Spironolactone—dilated cardiomyopathy	0.0029	0.0063	CcSEcCtD
Propofol—Agitation—Furosemide—dilated cardiomyopathy	0.00283	0.00616	CcSEcCtD
Propofol—Nausea—Spironolactone—dilated cardiomyopathy	0.00275	0.00597	CcSEcCtD
Propofol—Bradycardia—Lisinopril—dilated cardiomyopathy	0.0027	0.00588	CcSEcCtD
Propofol—Hallucination—Lisinopril—dilated cardiomyopathy	0.00264	0.00575	CcSEcCtD
Propofol—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.00264	0.00574	CcSEcCtD
Propofol—Dry mouth—Furosemide—dilated cardiomyopathy	0.00257	0.00558	CcSEcCtD
Propofol—Confusional state—Furosemide—dilated cardiomyopathy	0.00254	0.00552	CcSEcCtD
Propofol—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00252	0.00547	CcSEcCtD
Propofol—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00248	0.00539	CcSEcCtD
Propofol—Shock—Furosemide—dilated cardiomyopathy	0.00247	0.00538	CcSEcCtD
Propofol—Flushing—Lisinopril—dilated cardiomyopathy	0.00247	0.00536	CcSEcCtD
Propofol—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00243	0.00529	CcSEcCtD
Propofol—Chills—Lisinopril—dilated cardiomyopathy	0.00238	0.00519	CcSEcCtD
Propofol—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.00237	0.00516	CcSEcCtD
Propofol—Hypotension—Furosemide—dilated cardiomyopathy	0.00235	0.00511	CcSEcCtD
Propofol—Erythema—Lisinopril—dilated cardiomyopathy	0.00231	0.00503	CcSEcCtD
Propofol—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.00226	0.00493	CcSEcCtD
Propofol—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00226	0.00491	CcSEcCtD
Propofol—Somnolence—Furosemide—dilated cardiomyopathy	0.00224	0.00486	CcSEcCtD
Propofol—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.00222	0.00484	CcSEcCtD
Propofol—Fatigue—Furosemide—dilated cardiomyopathy	0.00217	0.00472	CcSEcCtD
Propofol—Tremor—Lisinopril—dilated cardiomyopathy	0.00217	0.00471	CcSEcCtD
Propofol—Pain—Furosemide—dilated cardiomyopathy	0.00215	0.00468	CcSEcCtD
Propofol—Angioedema—Lisinopril—dilated cardiomyopathy	0.00211	0.0046	CcSEcCtD
Propofol—Syncope—Lisinopril—dilated cardiomyopathy	0.00207	0.00451	CcSEcCtD
Propofol—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00207	0.00451	CcSEcCtD
Propofol—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00203	0.00442	CcSEcCtD
Propofol—Cough—Lisinopril—dilated cardiomyopathy	0.00202	0.00439	CcSEcCtD
Propofol—Urticaria—Furosemide—dilated cardiomyopathy	0.002	0.00435	CcSEcCtD
Propofol—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00199	0.00433	CcSEcCtD
Propofol—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00199	0.00433	CcSEcCtD
Propofol—Chest pain—Lisinopril—dilated cardiomyopathy	0.00197	0.00428	CcSEcCtD
Propofol—Myalgia—Lisinopril—dilated cardiomyopathy	0.00197	0.00428	CcSEcCtD
Propofol—Anxiety—Lisinopril—dilated cardiomyopathy	0.00196	0.00427	CcSEcCtD
Propofol—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00193	0.00419	CcSEcCtD
Propofol—Confusional state—Lisinopril—dilated cardiomyopathy	0.0019	0.00414	CcSEcCtD
Propofol—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.00189	0.00411	CcSEcCtD
Propofol—Oedema—Lisinopril—dilated cardiomyopathy	0.00189	0.00411	CcSEcCtD
Propofol—Shock—Lisinopril—dilated cardiomyopathy	0.00186	0.00404	CcSEcCtD
Propofol—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00184	0.00401	CcSEcCtD
Propofol—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00182	0.00397	CcSEcCtD
Propofol—Asthenia—Furosemide—dilated cardiomyopathy	0.0018	0.00393	CcSEcCtD
Propofol—Pruritus—Furosemide—dilated cardiomyopathy	0.00178	0.00387	CcSEcCtD
Propofol—Hypotension—Lisinopril—dilated cardiomyopathy	0.00176	0.00384	CcSEcCtD
Propofol—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00172	0.00374	CcSEcCtD
Propofol—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.00172	0.00374	CcSEcCtD
Propofol—Insomnia—Lisinopril—dilated cardiomyopathy	0.00171	0.00371	CcSEcCtD
Propofol—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00169	0.00369	CcSEcCtD
Propofol—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00168	0.00366	CcSEcCtD
Propofol—Somnolence—Lisinopril—dilated cardiomyopathy	0.00168	0.00365	CcSEcCtD
Propofol—Dizziness—Furosemide—dilated cardiomyopathy	0.00166	0.00362	CcSEcCtD
Propofol—Fatigue—Lisinopril—dilated cardiomyopathy	0.00163	0.00354	CcSEcCtD
Propofol—Pain—Lisinopril—dilated cardiomyopathy	0.00161	0.00351	CcSEcCtD
Propofol—Vomiting—Furosemide—dilated cardiomyopathy	0.0016	0.00348	CcSEcCtD
Propofol—Rash—Furosemide—dilated cardiomyopathy	0.00159	0.00345	CcSEcCtD
Propofol—Dermatitis—Furosemide—dilated cardiomyopathy	0.00158	0.00345	CcSEcCtD
Propofol—Headache—Furosemide—dilated cardiomyopathy	0.00158	0.00343	CcSEcCtD
Propofol—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00156	0.00338	CcSEcCtD
Propofol—Urticaria—Lisinopril—dilated cardiomyopathy	0.0015	0.00326	CcSEcCtD
Propofol—Nausea—Furosemide—dilated cardiomyopathy	0.00149	0.00325	CcSEcCtD
Propofol—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00149	0.00325	CcSEcCtD
Propofol—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00149	0.00325	CcSEcCtD
Propofol—Asthenia—Lisinopril—dilated cardiomyopathy	0.00135	0.00295	CcSEcCtD
Propofol—Pruritus—Lisinopril—dilated cardiomyopathy	0.00134	0.0029	CcSEcCtD
Propofol—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00129	0.00281	CcSEcCtD
Propofol—Dizziness—Lisinopril—dilated cardiomyopathy	0.00125	0.00272	CcSEcCtD
Propofol—Vomiting—Lisinopril—dilated cardiomyopathy	0.0012	0.00261	CcSEcCtD
Propofol—Rash—Lisinopril—dilated cardiomyopathy	0.00119	0.00259	CcSEcCtD
Propofol—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00119	0.00259	CcSEcCtD
Propofol—Headache—Lisinopril—dilated cardiomyopathy	0.00118	0.00257	CcSEcCtD
Propofol—Nausea—Lisinopril—dilated cardiomyopathy	0.00112	0.00244	CcSEcCtD
Propofol—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	0.000475	0.00234	CbGpPWpGaD
Propofol—GABRA1—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.000472	0.00233	CbGpPWpGaD
Propofol—ALB—Folate Metabolism—SOD2—dilated cardiomyopathy	0.000468	0.00231	CbGpPWpGaD
Propofol—GABRG2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000467	0.00231	CbGpPWpGaD
Propofol—GABRA2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000466	0.0023	CbGpPWpGaD
Propofol—GABRA2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000466	0.0023	CbGpPWpGaD
Propofol—GABRB3—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000463	0.00228	CbGpPWpGaD
Propofol—GABRB3—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000463	0.00228	CbGpPWpGaD
Propofol—GABRB2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000462	0.00228	CbGpPWpGaD
Propofol—CYP2C9—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000456	0.00225	CbGpPWpGaD
Propofol—GABRG2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000454	0.00224	CbGpPWpGaD
Propofol—GABRG2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000454	0.00224	CbGpPWpGaD
Propofol—ALB—Platelet activation, signaling and aggregation—ACTN2—dilated cardiomyopathy	0.000454	0.00224	CbGpPWpGaD
Propofol—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	0.000452	0.00223	CbGpPWpGaD
Propofol—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	0.000452	0.00223	CbGpPWpGaD
Propofol—SCN4A—Axon guidance—RAC1—dilated cardiomyopathy	0.000449	0.00221	CbGpPWpGaD
Propofol—SCN2A—Axon guidance—RAC1—dilated cardiomyopathy	0.000449	0.00221	CbGpPWpGaD
Propofol—ALB—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000447	0.00221	CbGpPWpGaD
Propofol—GABRB3—BDNF signaling pathway—RAC1—dilated cardiomyopathy	0.000447	0.0022	CbGpPWpGaD
Propofol—ALB—Folate Metabolism—GPX1—dilated cardiomyopathy	0.000446	0.0022	CbGpPWpGaD
Propofol—CYP1B1—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	0.000443	0.00219	CbGpPWpGaD
Propofol—CYP1B1—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	0.000443	0.00219	CbGpPWpGaD
Propofol—GABRA2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000433	0.00214	CbGpPWpGaD
Propofol—GABRB3—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00043	0.00212	CbGpPWpGaD
Propofol—GABRG2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000422	0.00208	CbGpPWpGaD
Propofol—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	0.000422	0.00208	CbGpPWpGaD
Propofol—CYP1B1—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	0.000422	0.00208	CbGpPWpGaD
Propofol—GABRA1—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.000409	0.00202	CbGpPWpGaD
Propofol—GABRA1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000408	0.00201	CbGpPWpGaD
Propofol—CYP1A2—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	0.000406	0.002	CbGpPWpGaD
Propofol—SCN4A—Developmental Biology—ITGB1—dilated cardiomyopathy	0.000398	0.00197	CbGpPWpGaD
Propofol—SCN2A—Developmental Biology—ITGB1—dilated cardiomyopathy	0.000398	0.00197	CbGpPWpGaD
Propofol—CYP1A1—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	0.000398	0.00196	CbGpPWpGaD
Propofol—GABRA1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000397	0.00196	CbGpPWpGaD
Propofol—GABRA1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000397	0.00196	CbGpPWpGaD
Propofol—CYP1A2—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.00039	0.00192	CbGpPWpGaD
Propofol—ALB—Platelet activation, signaling and aggregation—VCL—dilated cardiomyopathy	0.000386	0.00191	CbGpPWpGaD
Propofol—CYP1A1—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000378	0.00187	CbGpPWpGaD
Propofol—ALB—Platelet degranulation—CD36—dilated cardiomyopathy	0.000373	0.00184	CbGpPWpGaD
Propofol—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—dilated cardiomyopathy	0.000372	0.00184	CbGpPWpGaD
Propofol—ALB—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	0.000372	0.00183	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—ANKRD1—dilated cardiomyopathy	0.000371	0.00183	CbGpPWpGaD
Propofol—GABRA1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000369	0.00182	CbGpPWpGaD
Propofol—CYP1A1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000356	0.00176	CbGpPWpGaD
Propofol—ALB—Response to elevated platelet cytosolic Ca2+—CD36—dilated cardiomyopathy	0.000355	0.00175	CbGpPWpGaD
Propofol—ALB—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	0.000355	0.00175	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—TAZ—dilated cardiomyopathy	0.000349	0.00172	CbGpPWpGaD
Propofol—CYP2C8—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000347	0.00171	CbGpPWpGaD
Propofol—ALB—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000345	0.0017	CbGpPWpGaD
Propofol—SCN2A—Developmental Biology—CD36—dilated cardiomyopathy	0.00034	0.00168	CbGpPWpGaD
Propofol—SCN4A—Developmental Biology—CD36—dilated cardiomyopathy	0.00034	0.00168	CbGpPWpGaD
Propofol—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—dilated cardiomyopathy	0.000335	0.00165	CbGpPWpGaD
Propofol—CYP2C8—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000326	0.00161	CbGpPWpGaD
Propofol—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000325	0.00161	CbGpPWpGaD
Propofol—ALB—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000324	0.0016	CbGpPWpGaD
Propofol—SCN2A—Developmental Biology—RAC1—dilated cardiomyopathy	0.00032	0.00158	CbGpPWpGaD
Propofol—SCN4A—Developmental Biology—RAC1—dilated cardiomyopathy	0.00032	0.00158	CbGpPWpGaD
Propofol—CYP1A1—PPARA activates gene expression—CD36—dilated cardiomyopathy	0.000317	0.00156	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—SDHA—dilated cardiomyopathy	0.000315	0.00156	CbGpPWpGaD
Propofol—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CD36—dilated cardiomyopathy	0.00031	0.00153	CbGpPWpGaD
Propofol—CYP2C19—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.00031	0.00153	CbGpPWpGaD
Propofol—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000305	0.00151	CbGpPWpGaD
Propofol—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000303	0.0015	CbGpPWpGaD
Propofol—SCN4A—Axon guidance—RAF1—dilated cardiomyopathy	0.000297	0.00147	CbGpPWpGaD
Propofol—SCN2A—Axon guidance—RAF1—dilated cardiomyopathy	0.000297	0.00147	CbGpPWpGaD
Propofol—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000297	0.00147	CbGpPWpGaD
Propofol—GABRB3—BDNF signaling pathway—RAF1—dilated cardiomyopathy	0.000296	0.00146	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—ANKRD1—dilated cardiomyopathy	0.000293	0.00145	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—ANKRD1—dilated cardiomyopathy	0.000293	0.00145	CbGpPWpGaD
Propofol—CYP2C19—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000291	0.00144	CbGpPWpGaD
Propofol—GABRB2—Ion channel transport—RAF1—dilated cardiomyopathy	0.000289	0.00143	CbGpPWpGaD
Propofol—CYP1A1—PPARA activates gene expression—AGT—dilated cardiomyopathy	0.000285	0.00141	CbGpPWpGaD
Propofol—CYP2C9—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000282	0.00139	CbGpPWpGaD
Propofol—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—dilated cardiomyopathy	0.000279	0.00138	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—TAZ—dilated cardiomyopathy	0.000276	0.00136	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—TAZ—dilated cardiomyopathy	0.000276	0.00136	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—ANKRD1—dilated cardiomyopathy	0.000274	0.00135	CbGpPWpGaD
Propofol—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	0.000273	0.00135	CbGpPWpGaD
Propofol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	0.000273	0.00135	CbGpPWpGaD
Propofol—GABRA2—Ion channel transport—RAF1—dilated cardiomyopathy	0.000271	0.00134	CbGpPWpGaD
Propofol—ALB—Hemostasis—TTN—dilated cardiomyopathy	0.00027	0.00133	CbGpPWpGaD
Propofol—GABRB3—Ion channel transport—RAF1—dilated cardiomyopathy	0.000269	0.00133	CbGpPWpGaD
Propofol—CYP2C9—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000265	0.00131	CbGpPWpGaD
Propofol—GABRG2—Ion channel transport—RAF1—dilated cardiomyopathy	0.000265	0.00131	CbGpPWpGaD
Propofol—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.00026	0.00128	CbGpPWpGaD
Propofol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	0.00026	0.00128	CbGpPWpGaD
Propofol—CYP1A1—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	0.00026	0.00128	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—TAZ—dilated cardiomyopathy	0.000257	0.00127	CbGpPWpGaD
Propofol—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	0.000254	0.00125	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—SDHA—dilated cardiomyopathy	0.000249	0.00123	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—SDHA—dilated cardiomyopathy	0.000249	0.00123	CbGpPWpGaD
Propofol—GABRB2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000244	0.00121	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000241	0.00119	CbGpPWpGaD
Propofol—ALB—Hemostasis—ACTN2—dilated cardiomyopathy	0.000234	0.00116	CbGpPWpGaD
Propofol—ALB—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000234	0.00115	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—SDHA—dilated cardiomyopathy	0.000233	0.00115	CbGpPWpGaD
Propofol—GABRA1—Ion channel transport—RAF1—dilated cardiomyopathy	0.000231	0.00114	CbGpPWpGaD
Propofol—GABRA2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000229	0.00113	CbGpPWpGaD
Propofol—GABRB3—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000228	0.00112	CbGpPWpGaD
Propofol—ALB—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000227	0.00112	CbGpPWpGaD
Propofol—ALB—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000227	0.00112	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000227	0.00112	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—ANKRD1—dilated cardiomyopathy	0.000226	0.00112	CbGpPWpGaD
Propofol—GABRG2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000224	0.0011	CbGpPWpGaD
Propofol—ALB—Vitamin B12 Metabolism—TNF—dilated cardiomyopathy	0.000218	0.00108	CbGpPWpGaD
Propofol—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—dilated cardiomyopathy	0.000214	0.00105	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—TAZ—dilated cardiomyopathy	0.000213	0.00105	CbGpPWpGaD
Propofol—SCN2A—Developmental Biology—RAF1—dilated cardiomyopathy	0.000212	0.00105	CbGpPWpGaD
Propofol—SCN4A—Developmental Biology—RAF1—dilated cardiomyopathy	0.000212	0.00105	CbGpPWpGaD
Propofol—ALB—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000211	0.00104	CbGpPWpGaD
Propofol—UGT1A8—Metabolism—GPX1—dilated cardiomyopathy	0.000209	0.00103	CbGpPWpGaD
Propofol—SCN4A—Axon guidance—EGFR—dilated cardiomyopathy	0.000204	0.00101	CbGpPWpGaD
Propofol—SCN2A—Axon guidance—EGFR—dilated cardiomyopathy	0.000204	0.00101	CbGpPWpGaD
Propofol—UGT1A8—Metabolism—CD36—dilated cardiomyopathy	0.000204	0.00101	CbGpPWpGaD
Propofol—ALB—Hemostasis—VCL—dilated cardiomyopathy	0.000199	0.000982	CbGpPWpGaD
Propofol—GABRA1—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000195	0.000965	CbGpPWpGaD
Propofol—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—dilated cardiomyopathy	0.000192	0.00095	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—SDHA—dilated cardiomyopathy	0.000192	0.000949	CbGpPWpGaD
Propofol—GABRB2—Neuronal System—RAF1—dilated cardiomyopathy	0.000187	0.000925	CbGpPWpGaD
Propofol—UGT1A8—Metabolism—AGT—dilated cardiomyopathy	0.000184	0.000907	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—ANKRD1—dilated cardiomyopathy	0.000182	0.000901	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—ANKRD1—dilated cardiomyopathy	0.000179	0.000882	CbGpPWpGaD
Propofol—ALB—Folate Metabolism—TNF—dilated cardiomyopathy	0.000177	0.000876	CbGpPWpGaD
Propofol—GABRA2—Neuronal System—RAF1—dilated cardiomyopathy	0.000176	0.000867	CbGpPWpGaD
Propofol—GABRB3—Neuronal System—RAF1—dilated cardiomyopathy	0.000174	0.000861	CbGpPWpGaD
Propofol—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	0.000174	0.000858	CbGpPWpGaD
Propofol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	0.000174	0.000858	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—TAZ—dilated cardiomyopathy	0.000172	0.000847	CbGpPWpGaD
Propofol—GABRG2—Neuronal System—RAF1—dilated cardiomyopathy	0.000171	0.000846	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—ANKRD1—dilated cardiomyopathy	0.000168	0.000832	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—TAZ—dilated cardiomyopathy	0.000168	0.000829	CbGpPWpGaD
Propofol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	0.000166	0.000818	CbGpPWpGaD
Propofol—CYP1A2—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	0.000166	0.000818	CbGpPWpGaD
Propofol—ALB—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	0.000165	0.000816	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—TAZ—dilated cardiomyopathy	0.000158	0.000782	CbGpPWpGaD
Propofol—ALB—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	0.000156	0.000769	CbGpPWpGaD
Propofol—GABRA1—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.000156	0.000769	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—SDHA—dilated cardiomyopathy	0.000155	0.000766	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—ANKRD1—dilated cardiomyopathy	0.000154	0.000762	CbGpPWpGaD
Propofol—ALB—Metabolism—ANKRD1—dilated cardiomyopathy	0.000154	0.000758	CbGpPWpGaD
Propofol—UGT1A6—Metabolism—GPX1—dilated cardiomyopathy	0.000153	0.000754	CbGpPWpGaD
Propofol—UGT1A9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000152	0.000751	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—SDHA—dilated cardiomyopathy	0.000152	0.00075	CbGpPWpGaD
Propofol—GABRA1—Neuronal System—RAF1—dilated cardiomyopathy	0.00015	0.000739	CbGpPWpGaD
Propofol—UGT1A6—Metabolism—CD36—dilated cardiomyopathy	0.000149	0.000735	CbGpPWpGaD
Propofol—UGT1A9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000148	0.000731	CbGpPWpGaD
Propofol—SCN2A—Developmental Biology—EGFR—dilated cardiomyopathy	0.000146	0.000719	CbGpPWpGaD
Propofol—SCN4A—Developmental Biology—EGFR—dilated cardiomyopathy	0.000146	0.000719	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—TAZ—dilated cardiomyopathy	0.000145	0.000717	CbGpPWpGaD
Propofol—ALB—Metabolism—TAZ—dilated cardiomyopathy	0.000144	0.000713	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—SDHA—dilated cardiomyopathy	0.000143	0.000707	CbGpPWpGaD
Propofol—CYP1B1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000142	0.0007	CbGpPWpGaD
Propofol—ALB—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	0.000141	0.000696	CbGpPWpGaD
Propofol—SCN2A—Developmental Biology—TNF—dilated cardiomyopathy	0.000139	0.000684	CbGpPWpGaD
Propofol—SCN4A—Developmental Biology—TNF—dilated cardiomyopathy	0.000139	0.000684	CbGpPWpGaD
Propofol—CYP1B1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000138	0.000682	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—ANKRD1—dilated cardiomyopathy	0.000138	0.000681	CbGpPWpGaD
Propofol—UGT1A6—Metabolism—AGT—dilated cardiomyopathy	0.000134	0.000661	CbGpPWpGaD
Propofol—UGT1A9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000133	0.000659	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—SDHA—dilated cardiomyopathy	0.000131	0.000648	CbGpPWpGaD
Propofol—ALB—Metabolism—SDHA—dilated cardiomyopathy	0.000131	0.000645	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—TAZ—dilated cardiomyopathy	0.00013	0.00064	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—ANKRD1—dilated cardiomyopathy	0.000127	0.000626	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—ANKRD1—dilated cardiomyopathy	0.000126	0.000621	CbGpPWpGaD
Propofol—CYP1B1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000124	0.000614	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—TAZ—dilated cardiomyopathy	0.000119	0.000589	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—TAZ—dilated cardiomyopathy	0.000118	0.000583	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—SDHA—dilated cardiomyopathy	0.000117	0.000579	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—SDHA—dilated cardiomyopathy	0.000108	0.000532	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—ANKRD1—dilated cardiomyopathy	0.000107	0.00053	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—SDHA—dilated cardiomyopathy	0.000107	0.000528	CbGpPWpGaD
Propofol—ALB—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	0.000103	0.00051	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—TAZ—dilated cardiomyopathy	0.000101	0.000499	CbGpPWpGaD
Propofol—GABRB2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000101	0.000497	CbGpPWpGaD
Propofol—ALB—Hemostasis—ITGB1—dilated cardiomyopathy	9.99e-05	0.000493	CbGpPWpGaD
Propofol—GABRA2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	9.44e-05	0.000466	CbGpPWpGaD
Propofol—GABRB3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	9.38e-05	0.000463	CbGpPWpGaD
Propofol—GABRG2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	9.21e-05	0.000455	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—SDHA—dilated cardiomyopathy	9.13e-05	0.000451	CbGpPWpGaD
Propofol—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	8.74e-05	0.000431	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—GPX1—dilated cardiomyopathy	8.57e-05	0.000423	CbGpPWpGaD
Propofol—ALB—Hemostasis—CD36—dilated cardiomyopathy	8.52e-05	0.000421	CbGpPWpGaD
Propofol—CYP1A1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	8.51e-05	0.00042	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—CD36—dilated cardiomyopathy	8.35e-05	0.000412	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	8.29e-05	0.000409	CbGpPWpGaD
Propofol—GABRA1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	8.05e-05	0.000397	CbGpPWpGaD
Propofol—ALB—Hemostasis—RAC1—dilated cardiomyopathy	8.03e-05	0.000396	CbGpPWpGaD
Propofol—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	8.01e-05	0.000395	CbGpPWpGaD
Propofol—ALB—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	7.96e-05	0.000393	CbGpPWpGaD
Propofol—CYP2C8—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	7.8e-05	0.000385	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	7.79e-05	0.000385	CbGpPWpGaD
Propofol—ALB—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	7.76e-05	0.000383	CbGpPWpGaD
Propofol—CYP1A1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	7.66e-05	0.000378	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—AGT—dilated cardiomyopathy	7.51e-05	0.000371	CbGpPWpGaD
Propofol—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	7.15e-05	0.000353	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	7.05e-05	0.000348	CbGpPWpGaD
Propofol—CYP2C8—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	7.02e-05	0.000347	CbGpPWpGaD
Propofol—ALB—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	6.98e-05	0.000345	CbGpPWpGaD
Propofol—CYP2C19—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	6.96e-05	0.000344	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—GPX1—dilated cardiomyopathy	6.77e-05	0.000334	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—GPX1—dilated cardiomyopathy	6.77e-05	0.000334	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—CD36—dilated cardiomyopathy	6.6e-05	0.000326	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—CD36—dilated cardiomyopathy	6.6e-05	0.000326	CbGpPWpGaD
Propofol—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	6.52e-05	0.000322	CbGpPWpGaD
Propofol—CYP2C9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	6.35e-05	0.000313	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—GPX1—dilated cardiomyopathy	6.32e-05	0.000312	CbGpPWpGaD
Propofol—CYP2C19—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	6.27e-05	0.00031	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—CD36—dilated cardiomyopathy	6.15e-05	0.000304	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—AGT—dilated cardiomyopathy	5.94e-05	0.000293	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—AGT—dilated cardiomyopathy	5.94e-05	0.000293	CbGpPWpGaD
Propofol—CYP2C9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	5.72e-05	0.000282	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	5.57e-05	0.000275	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—AGT—dilated cardiomyopathy	5.54e-05	0.000274	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	5.43e-05	0.000268	CbGpPWpGaD
Propofol—ALB—Hemostasis—RAF1—dilated cardiomyopathy	5.32e-05	0.000263	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—GPX1—dilated cardiomyopathy	5.22e-05	0.000258	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—CD36—dilated cardiomyopathy	5.09e-05	0.000251	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	4.88e-05	0.000241	CbGpPWpGaD
Propofol—ALB—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	4.61e-05	0.000228	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—AGT—dilated cardiomyopathy	4.58e-05	0.000226	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—GPX1—dilated cardiomyopathy	4.21e-05	0.000208	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—GPX1—dilated cardiomyopathy	4.13e-05	0.000204	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—CD36—dilated cardiomyopathy	4.1e-05	0.000203	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—CD36—dilated cardiomyopathy	4.02e-05	0.000198	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—GPX1—dilated cardiomyopathy	3.89e-05	0.000192	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—CD36—dilated cardiomyopathy	3.79e-05	0.000187	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—AGT—dilated cardiomyopathy	3.69e-05	0.000182	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—AGT—dilated cardiomyopathy	3.62e-05	0.000179	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—GPX1—dilated cardiomyopathy	3.57e-05	0.000176	CbGpPWpGaD
Propofol—ALB—Metabolism—GPX1—dilated cardiomyopathy	3.55e-05	0.000175	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—CD36—dilated cardiomyopathy	3.47e-05	0.000172	CbGpPWpGaD
Propofol—ALB—Metabolism—CD36—dilated cardiomyopathy	3.45e-05	0.000171	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—AGT—dilated cardiomyopathy	3.41e-05	0.000168	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—GPX1—dilated cardiomyopathy	3.18e-05	0.000157	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—AGT—dilated cardiomyopathy	3.13e-05	0.000154	CbGpPWpGaD
Propofol—ALB—Metabolism—AGT—dilated cardiomyopathy	3.11e-05	0.000154	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—CD36—dilated cardiomyopathy	3.1e-05	0.000153	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	2.93e-05	0.000145	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—GPX1—dilated cardiomyopathy	2.9e-05	0.000143	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	2.85e-05	0.000141	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—CD36—dilated cardiomyopathy	2.83e-05	0.00014	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—AGT—dilated cardiomyopathy	2.79e-05	0.000138	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	2.57e-05	0.000127	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—AGT—dilated cardiomyopathy	2.55e-05	0.000126	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—GPX1—dilated cardiomyopathy	2.48e-05	0.000122	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—CD36—dilated cardiomyopathy	2.42e-05	0.000119	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—AGT—dilated cardiomyopathy	2.18e-05	0.000107	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	1.91e-05	9.45e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	1.86e-05	9.21e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	1.68e-05	8.29e-05	CbGpPWpGaD
